Status:
COMPLETED
A Randomized Clinical Trial on Supplementation of DHA and AA to Preterm Infants
Lead Sponsor:
University of Oslo
Conditions:
Infant, Low Birth Weight
Eligibility:
All Genders
Up to 1 years
Phase:
NA
Brief Summary
A randomized, double-blind trial of docosahexaenoic and arachidonic acid supplementation in breast-fed preterm infants Background: Docosahexaenoic acid (DHA) and arachidonic acid (AA) are essential ...
Eligibility Criteria
Inclusion
- Birth weight \< 1500 g
- Born at one of 4 participating neonatal centers in Norway
Exclusion
- Cerebral haemorrhage (stage 3 or 4)
- Major congenital malformations that are supposed to affect growth and development
- Illness that require prolonged parenteral nutrition (\>4 weeks)
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00226187
Start Date
December 1 2003
Last Update
February 15 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Oslo
Oslo, Oslo County, Norway, 0316